Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [ 177 Lu]Lu-PSMA-I&T Therapy
Journal of Nuclear Medicine · 2024
DOI: 10.2967/jnumed.123.266871 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Sandra Resch und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, LMU University Hospital, LMU, Munich, Germany; sandra.resch@med.uni-muenchen.de. Hauptthemen laut MEDLINE: Radiometry, Lutetium, Single Photon Emission Computed Tomography Computed Tomography. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Internal dosimetry supports safe and effective patient management during radionuclide therapy. Yet, it is associated with high clinical workload, costs, and patient burden, as patient scans at multiple time points (MTPs) must be acquired. Dosimetry based on imaging at a single time point (STP) has continuously gained popularity. However, MTP protocols, used as a reference to judge the validity of STP dosimetry, differ depending on local requirements and deviate from the unknown patient-specific ground truth pharmacokinetics. The aim of this study was to compare the error and optimum time point for different STP approaches using different reference MTP protocols.
Methods
Whole-body SPECT/CT scans of 7 patients (7.4-8.9 GBq of [177Lu]Lu-PSMA-I&T) were scheduled at 24, 48, 72, and 168 h after injection. Sixty lesions, 14 kidneys, and 10 submandibular glands were delineated in the SPECT/CT data. Two curve models, that is, a mono- and a biexponential model, were fitted to the MTP data, in accordance with goodness-of-fit analysis (coefficients of variation, sum of squared errors). Three population-based STP approaches were compared: one method published by Hänscheid et al., one by Jackson et al., and one using population-based effective half-lives in the mono- or biexponential curve models. Percentage differences between STP and MTP dosimetry were evaluated.
Results
Goodness-of-fit parameters show that a monoexponential function and a biexponential function with shared population-based parameters and physical tail are reasonable reference models. When comparing both reference models, we observed maximum differences of -44%, -19%, and -28% in the estimated absorbed doses for lesions, kidneys, and salivary glands, respectively. STP dosimetry with an average deviation of less than 10% from MTP dosimetry may be feasible; however, this deviation and the optimum imaging time point showed a dependence on the chosen reference protocol.
Conclusion
STP dosimetry for [177Lu]Lu-PSMA therapy is promising to boost the integration of dosimetry into clinical routine. According to our patient cohort, 48 h after injection may be regarded as a compromise for STP dosimetry for lesions and at-risk organs. The results from this analysis show that a common gold standard for dosimetry is desirable to allow for reliable and comparable STP dosimetry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, LMU University Hospital, LMU, Munich, Germany; sandra.resch@med.uni-muenchen.de.
- Department of Nuclear Medicine, LMU University Hospital, LMU, Munich, Germany.
- Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California; and.
- Department of Nuclear Medicine, Technical University of Munich, Munich, Germany.
Zitieren
APA
Resch, S., Ziegler, S. I., Sheikh, G., Unterrainer, L. M., Zacherl, M. J., Bartenstein, P., Böning, G., Brosch-Lenz, J., & Delker, A. (2024). Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [ 177 Lu]Lu-PSMA-I&T Therapy. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.123.266871
Vancouver
Resch S, Ziegler SI, Sheikh G, Unterrainer LM, Zacherl MJ, Bartenstein P, et al. Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [ 177 Lu]Lu-PSMA-I&T Therapy. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.123.266871
BibTeX
@article{Resch2024,
author = {Resch, Sandra and Ziegler, Sibylle I and Sheikh, Gabriel and Unterrainer, Lena M and Zacherl, Mathias J and Bartenstein, Peter and Böning, Guido and Brosch-Lenz, Julia and Delker, Astrid},
title = {Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [ 177 Lu]Lu-PSMA-I&T Therapy},
journal = {Journal of Nuclear Medicine},
year = {2024},
doi = {10.2967/jnumed.123.266871}
}
EUVIMED